ArticleNature medicine2026

Talazoparib plus enzalutamide in high-volume metastatic hormone-naive prostate cancer: a randomized phase 2 trial.

Francesca Zacchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.